Share chart ChemoCentryx, Inc.
Extended chart
Simple chart
About ChemoCentryx, Inc.
ChemoCentryx, Inc., биофармацевтическая компания, работающая на клинической стадии, специализируется на разработке и коммерциализации новых лекарств от воспалительных заболеваний, аутоиммунных заболеваний и рака в Соединенных Штатах. more detailsIPO date | 2012-02-08 |
---|---|
ISIN | US16383L1061 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Див.доход ао | 0 |
Сайт | https://www.chemocentryx.com |
Цена ао | 51.89 |
Change price per day: | 0% (51.99) |
---|---|
Change price per week: | 0% (51.99) |
Change price per month: | 0% (51.99) |
Change price per 3 month: | 0% (51.99) |
Change price per half year: | 0% (51.99) |
Change price per year: | 0% (51.99) |
Change price per 3 year: | +215.28% (16.49) |
Change price per 5 year: | -2.82% (53.5) |
Change price per 10 year: | +549.88% (8) |
Change price per year to date: | 0% (51.99) |
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
Transaction date | Date of disclosure | Insider | Type | Price | Volume | Quantity | Share before, % | Share after, % | Document |
---|---|---|---|---|---|---|---|---|---|
04.08.2022 | 08.08.2022 | Cappel Markus J. Chief Bus. Officer & Treasurer |
Sale | 50.22 | 379 864 | 7564 | 0 | -0.01 | link |
04.08.2022 | 08.08.2022 | Tyree James L Director |
Sale | 50.22 | 502 200 | 10000 | 0 | -0.01 | link |
04.08.2022 | 08.08.2022 | KANAYA SUSAN M EVP, CFO and Sec. |
Sale | 50.17 | 2 322 770 | 46298 | 0 | -0.07 | link |
04.08.2022 | 08.08.2022 | KANAYA SUSAN M EVP, CFO and Sec. |
Purchase | 6.5 | 300 937 | 46298 | 0 | 0.07 | link |
04.08.2022 | 08.08.2022 | Schall Thomas J. President and CEO |
Sale | 50.24 | 6 531 200 | 130000 | 0 | -0.19 | link |
20.05.2022 | 24.05.2022 | Jain Rita EVP, Chief Medical Officer |
Purchase | 21.41 | 165 414 | 7726 | 0 | 0.01 | link |
20.05.2022 | 24.05.2022 | MCKINNELL HENRY A Director |
Purchase | 21.41 | 165 414 | 7726 | 0 | 0.01 | link |
27.03.2022 | 29.03.2022 | Jain Rita EVP, Chief Medical Officer |
Purchase | 25.71 | 135 003 | 5251 | 0 | 0.01 | link |
Head | Job title | Payment | Year of birth |
---|---|---|---|
Dr. Thomas J. Schall Ph.D. | Founder, Pres, CEO & Chairman | 1.21M | 1959 (66 years) |
Ms. Susan M. Kanaya | Exec. VP, Chief Financial & Admin. Officer, Sec. and Director | 845.04k | 1963 (62 years) |
Mr. Tausif Butt | Exec. VP & COO | 1.01M | 1966 (59 years) |
Ms. Kari E. Leetch | Sr. VP of HR | N/A | |
Dr. Sangita Ghosh Ph.D. | Sr. VP of Technical Operations | N/A | |
Dr. Rita I. Jain M.D. | Exec. VP, Chief Medical Officer & Exec. Employee Director | 670.7k | 1963 (62 years) |
Dr. Markus J. Cappel Ph.D. | Chief Bus. Officer & Treasurer | 643.58k | 1961 (64 years) |
Ms. Yi Ching Yau | Sr. VP of Fin. & Principal Accounting Officer | N/A | 1976 (49 years) |
Mr. William S. Slattery | VP of Investor Relations & Corp. Communications | N/A |
Address: United States, San Carlos, 835 Industrial Avenue - open in Google maps, open in Yandex maps
Website: https://www.chemocentryx.com
Website: https://www.chemocentryx.com